Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates
-
RYVYL to Announce First Quarter 2023 Financial Results on Tuesday, May 14, 2024
-
The Vita Coco Company to Participate in the Goldman Sachs Global Staples Forum
-
Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac
-
HAProxy Enterprise 2.9 Sets the Security Standard for Application Delivery
-
Duos Technologies Group Sets First Quarter 2024 Earnings Call for Monday, May 13, 2024 at 4:30 PM ET
-
aTyr Pharma to Present at Upcoming Investor Conferences
-
Biora Therapeutics to Present Clinical Data on Device Function of the NaviCap™ Oral Delivery Platform at Digestive Disease Week 2024
-
Iterum Therapeutics to Report First Quarter 2024 Financial Results on May 13, 2024
-
Arqit Sets First Half 2024 Conference Call for Monday, May 20, 2024 at 11:00 a.m. ET
-
Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
-
Sagimet Biosciences Announces Appointment of Thierry Chauche as Chief Financial Officer
-
Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference
-
Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference
-
New Funding from The Allstate Foundation Will Expand Youth-Led Service in Multiple States
-
Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia
-
Fulcrum Therapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Monday, May 13, 2024, at 8:00 a.m. ET
-
Fingerprint Cards AB (publ) signs patent license agreement with major global firm, the first of its kind in the company’s history
-
Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
Joni Sorsanen appointed CFO of Lassila & Tikanoja plc
-
EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA)
-
Allarity Therapeutics Exceeds Nasdaq’s Minimum Equity Requirement; Requests Voluntarily Withdrawal of Form S-1
-
Lyra Therapeutics Reports Topline Results from Phase 3 ENLIGHTEN 1 Trial for LYR-210 in Chronic Rhinosinusitis
-
Lophos Pharmaceuticals Corp. Enters Into Letter of Intent to Acquire the Assets of Magicactus.com
-
Uniti Group Inc. Announces Private Offering of Senior Secured Notes
-
Petrolympic holds a gold property in the Sudbury mining camp, in Ontario
-
Garrett Motion Inc. Announces Proposed Private Offering of $500 Million of Senior Notes Due 2032
-
Fairfax Announces the Passing of Eric Salsberg
-
Divestment of NKT Photonics approved by the Danish Business Authority
-
Trailbreaker Resources Receives Exploration Permit for Swan Target at Atsutla Gold Project
-
Vow ASA: Invitation to Vow ASA first quarter 2024 presentation and Q&A
-
Final auction amounts of mortgage covered bonds series 11F, 12E and 12F
-
Kforce Inc. Announces Transfer of Listing of Common Stock to the New York Stock Exchange
-
Spectral Medical Provides April Tigris Trial Update
-
Metasphere Labs Announces a Follow-Up Event Regarding Bitcoin’s Defi Revolution
-
Tyson Foods Reports Second Quarter 2024 Results
-
Plus Therapeutics Announces Private Placement Financing of up to $18 Million
-
Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences
-
ETFS Capital Files Definitive Proxy Statement and Releases Letter to Fellow WisdomTree Stockholders
-
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders
-
Dime Announces Expansion in Williamsburg With Deposit-Focused Group
-
Quipt Home Medical Corp. to Announce Fiscal Second Quarter 2024 Financial Results on May 15, 2024
-
ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants
-
Allot Announces the Appointment of Eyal Harari as Chief Executive Officer
-
Flow Capital Announces Repayment of USD 4.5 Million Investment
-
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
-
N2OFF: Save Foods to Target California’s Hemp Market
-
Skyward Specialty Announces Secondary Offering of Its Common Stock
-
Flash News: OKX Launches Cryptopedia Season 17 Campaign Featuring 6,666,666 Ultiverse Token Prize Pool

